Ameriprise Financial »

Apellis Pharmaceuticals shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $16M 718k 22.63
2025-06-30 $13M 750k 17.31
2025-03-31 $10M 467k 21.87
2024-12-31 $28M 883k 31.91
2024-09-30 $25M 860k 28.84
2024-06-30 $30M 784k 38.36
2024-03-31 $31M 531k 58.78
2023-09-30 $13M 352k 38.04
2023-06-30 $13M 141k 91.10
2023-03-31 $5.3M 80k 65.96
2022-12-31 $3.0M 58k 51.72
2022-09-30 $3.9M 57k 68.30
2022-06-30 $8.1M 179k 45.23
2022-03-31 $8.6M 170k 50.82
2021-12-31 $7.9M 167k 47.28
2021-09-30 $6.7M 203k 32.97
2021-06-30 $8.5M 134k 63.21
2019-12-31 $589k 19k 30.68
2019-09-30 $494k 21k 24.10
2019-06-30 $2.2M 88k 25.34
2019-03-31 $937k 48k 19.50